Roche Breast cancer drug can increase Patients’ lives

September 28, 2014 8:05 PM

7 0

Roche Breast cancer drug can increase Patients’ lives

Perjeta, a drug used in the treatment of advanced breast cancer has shown unprecedented survival benefits in a medical trial. According to researchers, patients who received the drug made by Roche (a Swiss drug maker) lived nearly 16 months longer.

Most of the drugs used with patients suffering from metastatic disease prolongs their life up to few months, but patients who were given Perjeta ended up living 16 months more. “We’ve never seen anything like this before,” said Dr. Sandra M. Swain of the MedStar Washington Hospital Center in Washing...

Read more

To category page

Loading...